subject: Rheumatoid Arthritis - Drug Pipeline Analysis And Market Forecasts To 2015---aarkstore Enterprise [print this page] Rheumatoid Arthritis - Drug Pipeline Analysis and Market Forecasts to 2015
Summary
The industry analysis specialist, has released a new report on the Pharmaceutical and Healthcare industry, Rheumatoid Arthritis - Drug Pipeline Analysis and Market Forecasts to 2015. The report is an essential source of information and analysis on the global Rheumatoid Arthritis (RA) market. The report identifies the key trends shaping and driving the global RA market, a key segment within the pharma industry. The report also provides insight on the prevalent competitive landscape and the emerging players expected to cause significant shifts in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global RA sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by the team of industry experts.
Scope
The scope of the report includes:
*
Annualized global rheumatoid arthritis market revenues data from 2000 to 2008, forecast forward for 7 years to 2015.
*
Geographies covered in this report include the US, the UK, Italy, Spain, Germany, France, and Japan.
*
Pipeline analysis data providing a split across different phases, mechanism of action being developed and emerging trends. Key classes of mechanism of action includes CD targetters, THF dehydrogenase targetters, TNF targetters, COX targetters, Interleukin targetters, kinase targetters, and Cytokine targetters other than TNF.
*
Analysis of the current and future market competition in the global rheumatoid arthritis market. Key market players covered are Pfizer Inc., Roche, Biogen Idec, Amgen Inc. and Mitsubishi Tanabe Pharma.
*
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications.
*
Key topics covered include strategic competitor assessment, market characterization, unmet needs and implications for future market associated with rheumatoid arthritis.
